HomeHealth & FitnessGaucher Disease Market 2023, Size, Demand, Scope, Growth And Forecast 2028

Gaucher Disease Market 2023, Size, Demand, Scope, Growth And Forecast 2028

IMARC Group’s report titled “Gaucher Disease Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global Gaucher disease market size reached US$ 1.55 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.35 Billion by 2028, exhibiting a growth rate (CAGR) of 7.07% during 2023-2028.

Gaucher disease, also called as lysosomal storage disorder, is a rare genetic metabolic condition that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in an individual. Gaucher disease is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, bone abnormalities, etc. It can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, substrate reduction therapy (SRT), etc., which aid in minimizing the pain associated with the symptoms and improve the quality of life.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/gaucher-disease-market/requestsample

Gaucher Disease Market Trends and Drivers:

The growing prevalence of genetic abnormalities among consumers and the rising number of patients suffering from this disorder are among the key elements stimulating the Gaucher disease market. Moreover, the expanding aging population that is more prone to developing these medical conditions is resulting in an increasing demand for the treatment, which is also propelling the market growth. Besides this, the launch of health insurance policies that provide financial assistance for Gaucher disease therapy and reduce therapeutics expenses is acting as another significant growth-inducing factor.

 

Furthermore, the increasing awareness about the easy availability of ERT treatment alternatives, including oral treatments that help break down glucocerebroside and reduce the accumulation, is positively influencing the global market. Apart from this, government bodies of numerous countries are investing in research and development (R&D) activities to study this disorder and develop new therapies and are undertaking measures to offer quality healthcare facilities that are accessible to all, which is anticipated to fuel the Gaucher disease market over the forecasted period.

Report Segmentation:

The report has segmented the market into the following categories:

Type Insights:

  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Others

 

Diagnosis and Treatment Insights:

  • Diagnosis
    • Physical Exam
    • Blood Tests
    • Imaging Tests
    • Preconception Screening and Prenatal Testing
    • Others
  • Treatment
    • Surgery
    • Medication
    • Others

 

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • ISU Abxis Co. Ltd.
  • Johnson & Johnson
  • Pfizer Inc.
  • Protalix Biotherapeutics
  • Sanofi S.A
  • Takeda Pharmaceutical Company Limited

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

Must Read